The log-rank test was performed according to the clinical cut-off levels and demonstrated that the increased levels of IL-1β (>5 pg/mL) were associated with higher 3-month mortality in patients with AE-IPF (p < 0.001) (Figure 3). The gene discussed is IL1B; the disease is idiopathic pulmonary fibrosis.